SINGLE BLIND PLACEBO-CONTROLLED STUDY ON COMPARISION OF EFFECTS OF ZINGIBER OFFICINALE BEFORE AND AFTER TREATMENT IN HYPERLIPIDEMIA
Hyperlipidemia had have proved in many research studies causing atherosclerosis, coronary artery disease, angina and myocardial infarction. Hypolipidemic drugâ€™s low compliance made medicinal herbs to replace conventional hypolipidemic agents for treating primary or secondary hyperlipidemic patients. Zingiber Officinale (Ginger) is one of those medicinal herbs.Â This research was conducted at General Hospital Lahore Pakistan from March to May 2015. It was single-blind placebo controlled study. Inclusion criteria was primary and secondary hyperlipidemic patients age range from 18 to 65 years. Male and female patients were included in this work. Randomly selected eighty patients were divided in two equal numbers. Group-I was tested group and Group-II was on placebo therapy. Their base line values of LDL-cholesterol and plasma total cholesterol were measured in Biochemistry laboratory of the Hospital.Â When used in 40 hyperlipidemic patients this herbâ€™s paste preparation reduced LDL-cholesterol and plasma total cholesterol significantly. Mean values of LDL-cholesterol and plasma total cholesterol with SEM before and after treatment were calculated and analyzed biostatistically by using SPSS version 5.0. P-values >0.05 were used for non-significant change in parameters. P-values <0.01 and <0.001 were used for significant and highly significant changes respectively.
2. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 2010;91:2546-2551.
3. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2011;380:C719-41.
4. A.P. Kourounakis, P. Victoratos, N, Perulis, N. Stefanou, M. Jiangou, L. Hadjipetrou, P.N.Kourounakis.. Experimental hyperlipidemia and the effect of NSAIDs . Experimental and Molecular Pathology. 2012;73:135-138.
5. PE Schurr. Triton â€“ induced hyperlipidemia in rats as an animal model for screening hyperlipidemic drugs. Lipids. 2006;7:68-74.
6. Farmer JA, Torre-Amione G. Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf.2010;23:197-213.
7.Guh, J. H., Ko, F. N., Jong, T. T., and Teng, C. M. Antiplatelet effect of gingerol isolated from Zingiber officinale. J Pharm.Pharmacol. 2012;47(4):329-32.
8. Srivastava, K. C. Isolation and effects of some ginger components on platelet aggregation and eicosanoid biosynthesis. Prostaglandins Leukot Med 2009;25(2-3):187-98.
9. Verma, S. K., Singh, J., Khamesra, R., and Bordia, A. Effect of ginger on platelet aggregation in man. Indian J Med Res 2007;98:240-242.
10. Lumb, A. B. Effect of dried ginger on human platelet function. Thromb Haemost 2007;71(1):110-11.
11. Thomson M, Al Qattan KK, Al Sawan SM, et al. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids. 2008;67(6):475-78
12. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother. 2010;34(12):1478-82.
13. Bordia, A., Verma, S. K., and Srivastava, K. C. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 2010;56(5):379-84.
14. Janssen, P. L., Meyboom, S., van Staveren, W. A., de Vegt, F., and Katan, M. B. Consumption of ginger (Zingiber officinale) does affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 20013;50(11):772-74.
15. Srivastava, K. C. Effect of onion and ginger consumption on platelet thromboxane production in humans. Prostaglandins Leukot Essent Fatty Acids 2009;35(3):183-85.
16. Shoji, N., Iwasa, A., Takemoto, T., Ishida, Y., and Ohizumi, Y. Cardiotonic principles of ginger (Zingiber officinale). J Pharm.Sci 2010;71(10):1174-75.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).